1
↑0
↓1
—0
Evidence suggests Psilocybin maydecreaseDepression severity.
1 studies (1 claims)
Exact normalized-entity scope. Exact scope. Claims must match the selected normalized intervention and endpoint IDs; signal links are not expanded. Direction describes the stored endpoint phrase and is not a benefit/harm judgement.
1 of 1
| Intervention | Direction | Endpoint | Type | Population | Dosage | Title |
|---|---|---|---|---|---|---|
| psilocybin (0.3 mg/kg) | Decreases - strongly associated with reductions | depression severity | Human | individuals with moderate to severe MDD | 0.3 mg/kg psilocybin (single dose). | Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial.cited 17× |